サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1424018

gRNA市場、シェア、規模、動向、産業分析レポート：製品・サービス別、gRNAタイプ別、用途別、最終用途別、地域別、セグメント別予測、2024年～2032年

gRNA Market Share, Size, Trends, Industry Analysis Report, By Product & Services (Products, Custom gRNA Synthesis Services), By gRNA Type, By Application, By End-use, By Region, And Segment Forecast, 2024 - 2032
出版日: | 発行: Polaris Market Research | ページ情報: 英文 119 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.53円
gRNA市場、シェア、規模、動向、産業分析レポート：製品・サービス別、gRNAタイプ別、用途別、最終用途別、地域別、セグメント別予測、2024年～2032年
出版日: 2024年01月24日
発行: Polaris Market Research
ページ情報: 英文 119 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Polaris Market Research社の最新調査によると、世界のgRNA市場規模は2032年までに23億5,717万米ドルに達する見込みです。この調査レポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

同市場は、バイオテクノロジー企業や製薬企業による研究開発活動への投資の高まりによって、今後の成長が見込まれています。ユーザーフレンドリーで費用対効果の高いgRNA合成キットやサービスの登場により、CRISPR-Cas9技術へのアクセスが民主化され、さまざまな専門レベルの研究者に対応できるようになりました。CRISPR-Cas9の新たなアプリケーションの継続的な探求は、gRNAの持続的な需要に貢献しています。

NGSの採用増加はマーケット成長の重要な触媒です。NGS技術の普及により、研究者はゲノム解析と操作のための高度なツールを手に入れることができます。NGSはハイスループットでの効率的な遺伝子配列決定を可能にし、ゲノム全体を調べる迅速かつコスト効率の高い手段を提供します。この効率性は、遺伝子操作のための標的遺伝子の同定と検証を合理化するgRNAアプリケーションにとって特に重要です。この精度は、CRISPR/Casシステムを用いて特異性の高いgRNAを作製する上で不可欠です。

さらに、新しい最終的なgRNA製品のイントロダクションは、イノベーションを刺激する可能性を秘めています。例えば、2023年10月には、IND可能なgRNAを提供するSynthego社が登場します。この画期的な製品は、GLPで規制された前臨床試験やIND取得を可能にする研究に合わせた、綿密に設計された高品質のgRNAを研究者に提供することで、CRISPRベースの細胞・遺伝子治療前臨床パイプラインの大きな進歩を意味します。

生産量を拡大することは困難であり、適切な試薬、材料、設備へのアクセスによって制約を受ける可能性があります。治療法が自己由来であるか同種であるかにかかわらず、重要な課題は、手作業から商業的に自動化された製造への移行にあります。この移行には、全プロセスを通じて均一性を達成し、規制を確実に遵守することが必要です。例えば、細胞・遺伝子治療におけるウイルスベクターの不足率は500%を超えると推定されています。

gRNA市場レポートハイライト

主に進行中の臨床試験と分子研究目的により、研究用途セグメントが市場を独占しています。

ゲノムおよびプロテオミクスの進歩により、ゲノム工学分野が最大のシェアを占める

個別化治療におけるgRNAの採用により、製薬会社が最大シェアを獲得

アジア太平洋地域は、主にアンメット・メディカル・ニーズの存在と同分野の技術革新により急成長すると思われます。

市場参入企業には、Agilent Technologies、Horizon Discovery、Jena Bioscience、Merck、Synbio Technologies、Synthego、Takara Bio Inc.などが含まれます。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界のgRNA市場に関する洞察

  • gRNA-業界スナップショット
  • gRNA市場力学
    • 促進要因と機会
      • プロテオミクスとゲノミクスにおけるイノベーション
      • 個別化された治療の必要性の高まり
    • 抑制要因と課題
      • スケーラビリティと容量不足により成長が制限される
  • PESTLE分析
  • gRNA業界の動向
  • バリューチェーン分析
  • COVID-19感染症の影響分析

第5章 世界のgRNA市場、製品・サービス別

  • 主な調査結果
  • イントロダクション
  • 製品
  • カスタムgRNA合成サービス

第6章 世界のgRNA市場、gRNAタイプ別

  • 主な調査結果
  • イントロダクション
  • 研究利用
  • GMPグレード

第7章 世界のgRNA市場、用途別

  • 主な調査結果
  • イントロダクション
  • ゲノム工学
  • 疾患モデル研究
  • 機能的ゲノミクス
  • エピジェネティクス
  • その他

第8章 世界のgRNA市場、最終用途別

  • 主な調査結果
  • イントロダクション
  • 製薬およびバイオテクノロジー企業
  • 学術調査機関
  • CMOとCRO

第9章 世界のgRNA市場、地域別

  • 主な調査結果
  • イントロダクション
    • gRNA市場評価、地域別、2019-2032年
  • gRNA市場-北米
    • 北米：gRNA市場、製品・サービス別、2019-2032年
    • 北米：gRNA市場、最終用途別、2019-2032年
    • 北米：gRNA市場、gRNAタイプ別、2019-2032年
    • 北米：gRNA市場、用途別、2019-2032年
    • gRNA市場-米国
    • gRNA市場- カナダ
  • gRNA市場- 欧州
    • 欧州：gRNA市場、製品・サービス別、2019～2032年
    • 欧州：gRNA市場、最終用途別、2019-2032
    • 欧州：gRNA市場、gRNAタイプ別、2019～2032年
    • 欧州：gRNA市場、用途別、2019～2032年
    • gRNA市場- 英国
    • gRNA市場- フランス
    • gRNA市場- ドイツ
    • gRNA市場- イタリア
    • gRNA市場- スペイン
    • gRNA市場- オランダ
    • gRNA市場- ロシア
  • gRNA市場- アジア太平洋
    • アジア太平洋：gRNA市場、製品・サービス別、2019～2032年
    • アジア太平洋：gRNA市場、最終用途別、2019～2032年
    • アジア太平洋：gRNA市場、gRNAタイプ別、2019～2032年
    • アジア太平洋：gRNA市場、用途別、2019～2032年
    • gRNA市場- 中国
    • gRNA市場- インド
    • gRNA市場- 日本
    • gRNA市場- マレーシア
    • gRNA市場- インドネシア
    • gRNA市場- 韓国
  • gRNA市場-中東およびアフリカ
    • 中東およびアフリカ：gRNA市場、製品・サービス別、2019-2032年
    • 中東およびアフリカ：gRNA市場、最終用途別、2019～2032年
    • 中東およびアフリカ：gRNA市場、gRNAタイプ別、2019～2032年
    • 中東およびアフリカ：gRNA市場、用途別、2019～2032年
    • gRNA市場- サウジアラビア
    • gRNA市場- 南アフリカ
    • gRNA市場- イスラエル
    • gRNA市場- アラブ首長国連邦
  • gRNA市場-ラテンアメリカ
    • ラテンアメリカ：gRNA市場、製品・サービス別、2019-2032年
    • ラテンアメリカ：gRNA市場、最終用途別、2019-2032年
    • ラテンアメリカ：gRNA市場、gRNAタイプ別、2019-2032年
    • ラテンアメリカ：gRNA市場、用途別、2019-2032年
    • gRNA市場- メキシコ
    • gRNA市場- ブラジル
    • gRNA市場- アルゼンチン

第10章 競合情勢

  • 拡張と買収の分析
    • 拡大
    • 買収
  • 提携/協業/合意/公開

第11章 企業プロファイル

  • Agilent Technologies Inc.
  • GENEWIZ（Azenta Life Sciences）
  • Horizon Discovery Ltd.
  • Jena Bioscience GmbH
  • Merck KGaA
  • Synbio Technologies
  • Synthego
  • System Biosciences, LLC.
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc
図表

List of Tables

  • Table 1 Global gRNA Market, by Product & Services, by Region, 2019-2032 (USD Million)
  • Table 2 Global gRNA Market, by gRNA Type, by Region, 2019-2032 (USD Million)
  • Table 3 Global gRNA Market, by Application, by Region, 2019-2032 (USD Million)
  • Table 4 Global gRNA Market, by End-Use, by Region, 2019-2032 (USD Million)
  • Table 5 gRNA Market Assessment, By Geography, 2019-2032 (USD Million)
  • Table 6 North America: gRNA Market, by Product & Services, 2019-2032 (USD Million)
  • Table 7 North America: gRNA Market, by gRNA Type, 2019-2032 (USD Million)
  • Table 8 North America: gRNA Market, by Application, 2019-2032 (USD Million)
  • Table 9 North America: gRNA Market, by End-Use, 2019-2032 (USD Million)
  • Table 10 U.S.: gRNA Market, by Product & Services, 2019-2032 (USD Million)
  • Table 11 U.S.: gRNA Market, by gRNA Type, 2019-2032 (USD Million)
  • Table 12 U.S.: gRNA Market, by Application, 2019-2032 (USD Million)
  • Table 13 U.S.: gRNA Market, by End-Use, 2019-2032 (USD Million)
  • Table 14 Canada: gRNA Market, by Product & Services, 2019-2032 (USD Million)
  • Table 15 Canada: gRNA Market, by gRNA Type, 2019-2032 (USD Million)
  • Table 16 Canada: gRNA Market, by Application, 2019-2032 (USD Million)
  • Table 17 Canada: gRNA Market, by End-Use, 2019-2032 (USD Million)
  • Table 18 Europe: gRNA Market, by Product & Services, 2019-2032 (USD Million)
  • Table 19 Europe: gRNA Market, by gRNA Type, 2019-2032 (USD Million)
  • Table 20 Europe: gRNA Market, by Application, 2019-2032 (USD Million)
  • Table 21 Europe: gRNA Market, by End-Use, 2019-2032 (USD Million)
  • Table 22 Germany: gRNA Market, by Product & Services, 2019-2032 (USD Million)
  • Table 23 Germany: gRNA Market, by gRNA Type, 2019-2032 (USD Million)
  • Table 24 Germany: gRNA Market, by Application, 2019-2032 (USD Million)
  • Table 25 Germany: gRNA Market, by End-Use, 2019-2032 (USD Million)
  • Table 26 France: gRNA Market, by Product & Services, 2019-2032 (USD Million)
  • Table 27 France: gRNA Market, by gRNA Type, 2019-2032 (USD Million)
  • Table 28 France: gRNA Market, by Application, 2019-2032 (USD Million)
  • Table 29 France: gRNA Market, by End-Use, 2019-2032 (USD Million)
  • Table 30 UK: gRNA Market, by Product & Services, 2019-2032 (USD Million)
  • Table 31 UK: gRNA Market, by gRNA Type, 2019-2032 (USD Million)
  • Table 32 UK: gRNA Market, by Application, 2019-2032 (USD Million)
  • Table 33 UK: gRNA Market, by End-Use, 2019-2032 (USD Million)
  • Table 34 Italy: gRNA Market, by Product & Services, 2019-2032 (USD Million)
  • Table 35 Italy: gRNA Market, by gRNA Type, 2019-2032 (USD Million)
  • Table 36 Italy: gRNA Market, by Application, 2019-2032 (USD Million)
  • Table 37 Italy: gRNA Market, by End-Use, 2019-2032 (USD Million)
  • Table 38 Netherlands: gRNA Market, by Product & Services, 2019-2032 (USD Million)
  • Table 39 Netherlands: gRNA Market, by gRNA Type, 2019-2032 (USD Million)
  • Table 40 Netherlands: gRNA Market, by Application, 2019-2032 (USD Million)
  • Table 41 Netherlands: gRNA Market, by End-Use, 2019-2032 (USD Million)
  • Table 42 Spain: gRNA Market, by Product & Services, 2019-2032 (USD Million)
  • Table 43 Spain: gRNA Market, by gRNA Type, 2019-2032 (USD Million)
  • Table 44 Spain: gRNA Market, by Application, 2019-2032 (USD Million)
  • Table 45 Spain: gRNA Market, by End-Use, 2019-2032 (USD Million)
  • Table 46 Russia: gRNA Market, by Product & Services, 2019-2032 (USD Million)
  • Table 47 Russia: gRNA Market, by gRNA Type, 2019-2032 (USD Million)
  • Table 48 Russia: gRNA Market, by Application, 2019-2032 (USD Million)
  • Table 49 Russia: gRNA Market, by End-Use, 2019-2032 (USD Million)
  • Table 50 Asia Pacific: gRNA Market, by Product & Services, 2019-2032 (USD Million)
  • Table 51 Asia Pacific: gRNA Market, by gRNA Type, 2019-2032 (USD Million)
  • Table 52 Asia Pacific: gRNA Market, by Application, 2019-2032 (USD Million)
  • Table 53 Asia Pacific: gRNA Market, by End-Use, 2019-2032 (USD Million)
  • Table 54 China: gRNA Market, by Product & Services, 2019-2032 (USD Million)
  • Table 55 China: gRNA Market, by gRNA Type, 2019-2032 (USD Million)
  • Table 56 China: gRNA Market, by Application, 2019-2032 (USD Million)
  • Table 57 China: gRNA Market, by End-Use, 2019-2032 (USD Million)
  • Table 58 Japan: gRNA Market, by Product & Services, 2019-2032 (USD Million)
  • Table 59 Japan: gRNA Market, by gRNA Type, 2019-2032 (USD Million)
  • Table 60 Japan: gRNA Market, by Application, 2019-2032 (USD Million)
  • Table 61 Japan: gRNA Market, by End-Use, 2019-2032 (USD Million)
  • Table 62 India: gRNA Market, by Product & Services, 2019-2032 (USD Million)
  • Table 63 India: gRNA Market, by gRNA Type, 2019-2032 (USD Million)
  • Table 64 India: gRNA Market, by Application, 2019-2032 (USD Million)
  • Table 65 India: gRNA Market, by End-Use, 2019-2032 (USD Million)
  • Table 66 Indonesia: gRNA Market, by Product & Services, 2019-2032 (USD Million)
  • Table 67 Indonesia: gRNA Market, by gRNA Type, 2019-2032 (USD Million)
  • Table 68 Indonesia: gRNA Market, by Application, 2019-2032 (USD Million)
  • Table 69 Indonesia: gRNA Market, by End-Use, 2019-2032 (USD Million)
  • Table 70 Malaysia: gRNA Market, by Product & Services, 2019-2032 (USD Million)
  • Table 71 Malaysia: gRNA Market, by gRNA Type, 2019-2032 (USD Million)
  • Table 72 Malaysia: gRNA Market, by Application, 2019-2032 (USD Million)
  • Table 73 Malaysia: gRNA Market, by End-Use, 2019-2032 (USD Million)
  • Table 74 South Korea: gRNA Market, by Product & Services, 2019-2032 (USD Million)
  • Table 75 South Korea: gRNA Market, by gRNA Type, 2019-2032 (USD Million)
  • Table 76 South Korea: gRNA Market, by Application, 2019-2032 (USD Million)
  • Table 77 South Korea: gRNA Market, by End-Use, 2019-2032 (USD Million)
  • Table 78 Latin America: gRNA Market, by Product & Services, 2019-2032 (USD Million)
  • Table 79 Latin America: gRNA Market, by gRNA Type, 2019-2032 (USD Million)
  • Table 80 Latin America: gRNA Market, by Application, 2019-2032 (USD Million)
  • Table 81 Latin America: gRNA Market, by End-Use, 2019-2032 (USD Million)
  • Table 82 Brazil: gRNA Market, by Product & Services, 2019-2032 (USD Million)
  • Table 83 Brazil: gRNA Market, by gRNA Type, 2019-2032 (USD Million)
  • Table 84 Brazil: gRNA Market, by Application, 2019-2032 (USD Million)
  • Table 85 Brazil: gRNA Market, by End-Use, 2019-2032 (USD Million)
  • Table 86 Mexico: gRNA Market, by Product & Services, 2019-2032 (USD Million)
  • Table 87 Mexico: gRNA Market, by gRNA Type, 2019-2032 (USD Million)
  • Table 88 Mexico: gRNA Market, by Application, 2019-2032 (USD Million)
  • Table 89 Mexico: gRNA Market, by End-Use, 2019-2032 (USD Million)
  • Table 90 Argentina: gRNA Market, by Product & Services, 2019-2032 (USD Million)
  • Table 91 Argentina: gRNA Market, by gRNA Type, 2019-2032 (USD Million)
  • Table 92 Argentina: gRNA Market, by Application, 2019-2032 (USD Million)
  • Table 93 Argentina: gRNA Market, by End-Use, 2019-2032 (USD Million)
  • Table 94 Middle East & Africa: gRNA Market, by Product & Services, 2019-2032 (USD Million)
  • Table 95 Middle East & Africa: gRNA Market, by gRNA Type, 2019-2032 (USD Million)
  • Table 96 Middle East & Africa: gRNA Market, by Application, 2019-2032 (USD Million)
  • Table 97 Middle East & Africa: gRNA Market, by End-Use, 2019-2032 (USD Million)
  • Table 98 UAE: gRNA Market, by Product & Services, 2019-2032 (USD Million)
  • Table 99 UAE: gRNA Market, by gRNA Type, 2019-2032 (USD Million)
  • Table 100 UAE: gRNA Market, by Application, 2019-2032 (USD Million)
  • Table 101 UAE: gRNA Market, by End-Use, 2019-2032 (USD Million)
  • Table 102 Saudi Arabia: gRNA Market, by Product & Services, 2019-2032 (USD Million)
  • Table 103 Saudi Arabia: gRNA Market, by gRNA Type, 2019-2032 (USD Million)
  • Table 104 Saudi Arabia: gRNA Market, by Application, 2019-2032 (USD Million)
  • Table 105 Saudi Arabia: gRNA Market, by End-Use, 2019-2032 (USD Million)
  • Table 106 South Africa: gRNA Market, by Product & Services, 2019-2032 (USD Million)
  • Table 107 South Africa: gRNA Market, by gRNA Type, 2019-2032 (USD Million)
  • Table 108 South Africa: gRNA Market, by Application, 2019-2032 (USD Million)
  • Table 109 South Africa: gRNA Market, by End-Use, 2019-2032 (USD Million)
  • Table 110 Israel: gRNA Market, by Product & Services, 2019-2032 (USD Million)
  • Table 111 Israel: gRNA Market, by gRNA Type, 2019-2032 (USD Million)
  • Table 112 Israel: gRNA Market, by Application, 2019-2032 (USD Million)
  • Table 113 Israel: gRNA Market, by End-Use, 2019-2032 (USD Million)

List of Figures

  • Figure 1. Global gRNA Market, 2019-2032 (USD Million)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up End-Use
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Product & Services
  • Figure 7. Global gRNA Market, by Product & Services, 2021 & 2030 (USD Million)
  • Figure 8. Market by End-Use
  • Figure 9. Global gRNA Market, by End-Use, 2021 & 2030 (USD Million)
  • Figure 10. Market by gRNA Type
  • Figure 11. Global gRNA Market, by gRNA Type, 2021 & 2030 (USD Million)
  • Figure 12. Market by Application
  • Figure 13. Global gRNA Market, by Application, 2021 & 2030 (USD Million)
目次
Product Code: PM4327

The global gRNA market size is expected to reach USD 2,357.17 million by 2032, according to a new study by Polaris Market Research. The report "gRNA Market Share, Size, Trends, Industry Analysis Report, By Product & Services (Products, Custom gRNA Synthesis Services), By gRNA Type, By Application, By End-use, By Region, And Segment Forecast, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The market is poised for future growth, driven by the escalating investments from biotechnology and pharmaceutical companies in R&D activities. The creation of user-friendly and cost-effective gRNA synthesis kits and services has democratized access to CRISPR-Cas9 technology, catering to researchers across various expertise levels. The ongoing exploration of new applications for CRISPR-Cas9 contributes to the sustained demand for gRNA.

The increasing adoption of NGS is a significant catalyst for market growth. The widespread use of NGS technologies equips researchers with advanced tools for genomic analysis & manipulation. NGS enables the efficient sequencing of genetic material at high throughput, offering a rapid and cost-effective means of examining entire genomes. This efficiency is particularly crucial for gRNA applications, streamlining the identification and validation of target genes for genetic manipulation. This precision is essential in crafting gRNAs with high specificity using CRISPR/Cas systems.

Moreover, the introduction of new final gRNA products has the potential to stimulate innovation. For instance, in October 2023, Synthego, provider of IND-enabling gRNAs. This groundbreaking offering represents a significant progression in the CRISPR-based cell & gene therapy preclinical pipeline by furnishing researchers with meticulously designed, high-quality gRNAs tailored for GLP-regulated preclinical & IND-enabling studies.

Expanding the production volume may pose difficulties and could be constrained by the accessibility of suitable reagents, materials, and equipment. Irrespective of whether the therapy is autologous or allogeneic, a significant challenge lies in transitioning from manual processes to commercially automated manufacturing. This shift necessitates achieving uniformity throughout the entire process and ensuring compliance with regulations. For instance, the shortage of viral vectors in the capacity for cell and gene therapy is estimated to exceed 500%.

gRNA Market Report Highlights

The research use segment dominated the market, primarily due to ongoing clinical trials and molecular research purposes

The genomic engineering segment held the largest share due to advances in genomic and proteomics

Pharmaceutical companies garnered the largest share due to the adoption of gRNA in personalized therapies

Asia Pacific will grow rapidly, primarily due to presence of unmet medical needs and innovations in the sector

The market players include Agilent Technologies, Horizon Discovery, Jena Bioscience, Merck, Synbio Technologies, Synthego, & Takara Bio Inc.

Polaris Market Research has segmented the gRNA market report based on product and services, gRNA type, application, end use, and region:

gRNA, Product and Services Outlook (Revenue - USD Million, 2019 - 2032)

  • Products
  • gRNA Final Products
  • gRNA Synthesis Products
  • gRNA Synthesis Kits
  • Plasmids
  • Others
  • Custom gRNA Synthesis Services

gRNA, Type Outlook (Revenue - USD Million, 2019 - 2032)

  • Research-Use
  • GMP-grade

gRNA, Application Outlook (Revenue - USD Million, 2019 - 2032)

  • Genome Engineering
  • Disease Model Studies
  • Functional Genomics
  • Epigenetics
  • Others

gRNA, End Use Outlook (Revenue - USD Million, 2019 - 2032)

  • Pharmaceutical & Biotechnology Companies
  • Academic Research Institutes
  • CMOs & CROs

gRNA, Regional Outlook (Revenue - USD Million, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global gRNA Market Insights

  • 4.1. gRNA - Industry Snapshot
  • 4.2. gRNA Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Innovations in proteomics and genomics
      • 4.2.1.2. Rising necessity of personalized treatment
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Scalability and capacity shortage limiting growth
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTLE Analysis
  • 4.5. gRNA Industry Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global gRNA Market, by Product & Services

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global gRNA Market, by Product & Services, 2019-2032 (USD Million)
  • 5.3. Products
    • 5.3.1. Global gRNA Market, by Products, by Region, 2019-2032 (USD Million)
    • 5.3.2. gRNA Final Products
      • 5.3.2.1. Global gRNA Market, by gRNA Final Products, by Region, 2019-2032 (USD Million)
    • 5.3.3. gRNA Synthesis Products
      • 5.3.3.1. Global gRNA Market, by gRNA Synthesis Products, by Region, 2019-2032 (USD Million)
      • 5.3.3.2. gRNA Synthesis Kits
      • 5.3.3.2.1. Global gRNA Market, by gRNA Synthesis Kits, by Region, 2019-2032 (USD Million)
      • 5.3.3.3. Plasmids
      • 5.3.3.3.1. Global gRNA Market, by Plasmids, by Region, 2019-2032 (USD Million)
      • 5.3.3.4. Others
      • 5.3.3.4.1. Global gRNA Market, by Others, by Region, 2019-2032 (USD Million)
  • 5.4. Custom gRNA Synthesis Services
    • 5.4.1. Global gRNA Market, by Custom gRNA Synthesis Services, by Region, 2019-2032 (USD Million)

6. Global gRNA Market, by gRNA Type

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global gRNA Market, by gRNA Type, 2019-2032 (USD Million)
  • 6.3. Research-Use
    • 6.3.1. Global gRNA Market, by Research-Use, by Region, 2019-2032 (USD Million)
  • 6.4. GMP-grade
    • 6.4.1. Global gRNA Market, by GMP-grade, by Region, 2019-2032 (USD Million)

7. Global gRNA Market, by Application

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global gRNA Market, by Application, 2019-2032 (USD Million)
  • 7.3. Genome Engineering
    • 7.3.1. Global gRNA Market, by Genome Engineering, by Region, 2019-2032 (USD Million)
  • 7.4. Disease Model Studies
    • 7.4.1. Global gRNA Market, by Disease Model Studies, by Region, 2019-2032 (USD Million)
  • 7.5. Functional Genomics
    • 7.5.1. Global gRNA Market, by Functional Genomics, by Region, 2019-2032 (USD Million)
  • 7.6. Epigenetics
    • 7.6.1. Global gRNA Market, by Epigenetics, by Region, 2019-2032 (USD Million)
  • 7.7. Others
    • 7.7.1. Global gRNA Market, by Others, by Region, 2019-2032 (USD Million)

8. Global gRNA Market, by End-Use

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global gRNA Market, by End-Use, 2019-2032 (USD Million)
  • 8.3. Pharmaceutical & Biotechnology Companies
    • 8.3.1. Global gRNA Market, by Pharmaceutical & Biotechnology Companies, by Region, 2019-2032 (USD Million)
  • 8.4. Academic Research Institutes
    • 8.4.1. Global gRNA Market, by Academic Research Institutes, by Region, 2019-2032 (USD Million)
  • 8.5. CMOs & CROs
    • 8.5.1. Global gRNA Market, by CMOs & CROs, by Region, 2019-2032 (USD Million)

9. Global gRNA Market, by Geography

  • 9.1. Key findings
  • 9.2. Introduction
    • 9.2.1. gRNA Market Assessment, By Geography, 2019-2032 (USD Million)
  • 9.3. gRNA Market - North America
    • 9.3.1. North America: gRNA Market, by Product & Services, 2019-2032 (USD Million)
    • 9.3.2. North America: gRNA Market, by End-Use, 2019-2032 (USD Million)
    • 9.3.3. North America: gRNA Market, by gRNA Type, 2019-2032 (USD Million)
    • 9.3.4. North America: gRNA Market, by Application, 2019-2032 (USD Million)
    • 9.3.5. gRNA Market - U.S.
      • 9.3.5.1. U.S.: gRNA Market, by Product & Services, 2019-2032 (USD Million)
      • 9.3.5.2. U.S.: gRNA Market, by End-Use, 2019-2032 (USD Million)
      • 9.3.5.3. U.S.: gRNA Market, by gRNA Type, 2019-2032 (USD Million)
      • 9.3.5.4. U.S.: gRNA Market, by Application, 2019-2032 (USD Million)
    • 9.3.6. gRNA Market - Canada
      • 9.3.6.1. Canada: gRNA Market, by Product & Services, 2019-2032 (USD Million)
      • 9.3.6.2. Canada: gRNA Market, by End-Use, 2019-2032 (USD Million)
      • 9.3.6.3. Canada: gRNA Market, by gRNA Type, 2019-2032 (USD Million)
      • 9.3.6.4. Canada: gRNA Market, by Application, 2019-2032 (USD Million)
  • 9.4. gRNA Market - Europe
    • 9.4.1. Europe: gRNA Market, by Product & Services, 2019-2032 (USD Million)
    • 9.4.2. Europe: gRNA Market, by End-Use, 2019-2032 (USD Million)
    • 9.4.3. Europe: gRNA Market, by gRNA Type, 2019-2032 (USD Million)
    • 9.4.4. Europe: gRNA Market, by Application, 2019-2032 (USD Million)
    • 9.4.5. gRNA Market - UK
      • 9.4.5.1. UK: gRNA Market, by Product & Services, 2019-2032 (USD Million)
      • 9.4.5.2. UK: gRNA Market, by End-Use, 2019-2032 (USD Million)
      • 9.4.5.3. UK: gRNA Market, by gRNA Type, 2019-2032 (USD Million)
      • 9.4.5.4. UK: gRNA Market, by Application, 2019-2032 (USD Million)
    • 9.4.6. gRNA Market - France
      • 9.4.6.1. France: gRNA Market, by Product & Services, 2019-2032 (USD Million)
      • 9.4.6.2. France: gRNA Market, by End-Use, 2019-2032 (USD Million)
      • 9.4.6.3. France: gRNA Market, by gRNA Type, 2019-2032 (USD Million)
      • 9.4.6.4. France: gRNA Market, by Application, 2019-2032 (USD Million)
    • 9.4.7. gRNA Market - Germany
      • 9.4.7.1. Germany: gRNA Market, by Product & Services, 2019-2032 (USD Million)
      • 9.4.7.2. Germany: gRNA Market, by End-Use, 2019-2032 (USD Million)
      • 9.4.7.3. Germany: gRNA Market, by gRNA Type, 2019-2032 (USD Million)
      • 9.4.7.4. Germany: gRNA Market, by Application, 2019-2032 (USD Million)
    • 9.4.8. gRNA Market - Italy
      • 9.4.8.1. Italy: gRNA Market, by Product & Services, 2019-2032 (USD Million)
      • 9.4.8.2. Italy: gRNA Market, by End-Use, 2019-2032 (USD Million)
      • 9.4.8.3. Italy: gRNA Market, by gRNA Type, 2019-2032 (USD Million)
      • 9.4.8.4. Italy: gRNA Market, by Application, 2019-2032 (USD Million)
    • 9.4.9. gRNA Market - Spain
      • 9.4.9.1. Spain: gRNA Market, by Product & Services, 2019-2032 (USD Million)
      • 9.4.9.2. Spain: gRNA Market, by End-Use, 2019-2032 (USD Million)
      • 9.4.9.3. Spain: gRNA Market, by gRNA Type, 2019-2032 (USD Million)
      • 9.4.9.4. Spain: gRNA Market, by Application, 2019-2032 (USD Million)
    • 9.4.10. gRNA Market - Netherlands
      • 9.4.10.1. Netherlands: gRNA Market, by Product & Services, 2019-2032 (USD Million)
      • 9.4.10.2. Netherlands: gRNA Market, by End-Use, 2019-2032 (USD Million)
      • 9.4.10.3. Netherlands: gRNA Market, by gRNA Type, 2019-2032 (USD Million)
      • 9.4.10.4. Netherlands: gRNA Market, by Application, 2019-2032 (USD Million)
    • 9.4.11. gRNA Market - Russia
      • 9.4.11.1. Russia: gRNA Market, by Product & Services, 2019-2032 (USD Million)
      • 9.4.11.2. Russia.: gRNA Market, by End-Use, 2019-2032 (USD Million)
      • 9.4.11.3. Russia: gRNA Market, by gRNA Type, 2019-2032 (USD Million)
      • 9.4.11.4. Russia: gRNA Market, by Application, 2019-2032 (USD Million)
  • 9.5. gRNA Market - Asia Pacific
    • 9.5.1. Asia Pacific: gRNA Market, by Product & Services, 2019-2032 (USD Million)
    • 9.5.2. Asia Pacific: gRNA Market, by End-Use, 2019-2032 (USD Million)
    • 9.5.3. Asia Pacific: gRNA Market, by gRNA Type, 2019-2032 (USD Million)
    • 9.5.4. Asia Pacific: gRNA Market, by Application, 2019-2032 (USD Million)
    • 9.5.5. gRNA Market - China
      • 9.5.5.1. China: gRNA Market, by Product & Services, 2019-2032 (USD Million)
      • 9.5.5.2. China.: gRNA Market, by End-Use, 2019-2032 (USD Million)
      • 9.5.5.3. China: gRNA Market, by gRNA Type, 2019-2032 (USD Million)
      • 9.5.5.4. China: gRNA Market, by Application, 2019-2032 (USD Million)
    • 9.5.6. gRNA Market - India
      • 9.5.6.1. India: gRNA Market, by Product & Services, 2019-2032 (USD Million)
      • 9.5.6.2. India.: gRNA Market, by End-Use, 2019-2032 (USD Million)
      • 9.5.6.3. India: gRNA Market, by gRNA Type, 2019-2032 (USD Million)
      • 9.5.6.4. India: gRNA Market, by Application, 2019-2032 (USD Million)
    • 9.5.7. gRNA Market - Japan
      • 9.5.7.1. Japan: gRNA Market, by Product & Services, 2019-2032 (USD Million)
      • 9.5.7.2. Japan.: gRNA Market, by End-Use, 2019-2032 (USD Million)
      • 9.5.7.3. Japan: gRNA Market, by gRNA Type, 2019-2032 (USD Million)
      • 9.5.7.4. Japan: gRNA Market, by Application, 2019-2032 (USD Million)
    • 9.5.8. gRNA Market - Malaysia
      • 9.5.8.1. Malaysia: gRNA Market, by Product & Services, 2019-2032 (USD Million)
      • 9.5.8.2. Malaysia.: gRNA Market, by End-Use, 2019-2032 (USD Million)
      • 9.5.8.3. Malaysia: gRNA Market, by gRNA Type, 2019-2032 (USD Million)
      • 9.5.8.4. Malaysia: gRNA Market, by Application, 2019-2032 (USD Million)
    • 9.5.9. gRNA Market - Indonesia
      • 9.5.9.1. Indonesia: gRNA Market, by Product & Services, 2019-2032 (USD Million)
      • 9.5.9.2. Indonesia.: gRNA Market, by End-Use, 2019-2032 (USD Million)
      • 9.5.9.3. Indonesia: gRNA Market, by gRNA Type, 2019-2032 (USD Million)
      • 9.5.9.4. Indonesia: gRNA Market, by Application, 2019-2032 (USD Million)
    • 9.5.10. gRNA Market - South Korea
      • 9.5.10.1. South Korea: gRNA Market, by Product & Services, 2019-2032 (USD Million)
      • 9.5.10.2. South Korea.: gRNA Market, by End-Use, 2019-2032 (USD Million)
      • 9.5.10.3. South Korea: gRNA Market, by gRNA Type, 2019-2032 (USD Million)
      • 9.5.10.4. South Korea: gRNA Market, by Application, 2019-2032 (USD Million)
  • 9.6. gRNA Market - Middle East & Africa
    • 9.6.1. Middle East & Africa: gRNA Market, by Product & Services, 2019-2032 (USD Million)
    • 9.6.2. Middle East & Africa: gRNA Market, by End-Use, 2019-2032 (USD Million)
    • 9.6.3. Middle East & Africa: gRNA Market, by gRNA Type, 2019-2032 (USD Million)
    • 9.6.4. Middle East & Africa: gRNA Market, by Application, 2019-2032 (USD Million)
    • 9.6.5. gRNA Market - Saudi Arabia
      • 9.6.5.1. Saudi Arabia: gRNA Market, by Product & Services, 2019-2032 (USD Million)
      • 9.6.5.2. Saudi Arabia: gRNA Market, by End-Use, 2019-2032 (USD Million)
      • 9.6.5.3. Saudi Arabia: gRNA Market, by gRNA Type, 2019-2032 (USD Million)
      • 9.6.5.4. Saudi Arabia: gRNA Market, by Application, 2019-2032 (USD Million)
    • 9.6.6. gRNA Market - South Africa
      • 9.6.6.1. South Africa: gRNA Market, by Product & Services, 2019-2032 (USD Million)
      • 9.6.6.2. South Africa: gRNA Market, by End-Use, 2019-2032 (USD Million)
      • 9.6.6.3. South Africa: gRNA Market, by gRNA Type, 2019-2032 (USD Million)
      • 9.6.6.4. South Africa: gRNA Market, by Application, 2019-2032 (USD Million)
    • 9.6.7. gRNA Market - Israel
      • 9.6.7.1. Israel: gRNA Market, by Product & Services, 2019-2032 (USD Million)
      • 9.6.7.2. Israel: gRNA Market, by End-Use, 2019-2032 (USD Million)
      • 9.6.7.3. Israel: gRNA Market, by gRNA Type, 2019-2032 (USD Million)
      • 9.6.7.4. Israel: gRNA Market, by Application, 2019-2032 (USD Million)
    • 9.6.8. gRNA Market - UAE
      • 9.6.8.1. UAE: gRNA Market, by Product & Services, 2019-2032 (USD Million)
      • 9.6.8.2. UAE: gRNA Market, by End-Use, 2019-2032 (USD Million)
      • 9.6.8.3. UAE: gRNA Market, by gRNA Type, 2019-2032 (USD Million)
      • 9.6.8.4. UAE: gRNA Market, by Application, 2019-2032 (USD Million)
  • 9.7. gRNA Market - Latin America
    • 9.7.1. Latin America: gRNA Market, by Product & Services, 2019-2032 (USD Million)
    • 9.7.2. Latin America: gRNA Market, by End-Use, 2019-2032 (USD Million)
    • 9.7.3. Latin America: gRNA Market, by gRNA Type, 2019-2032 (USD Million)
    • 9.7.4. Latin America: gRNA Market, by Application, 2019-2032 (USD Million)
    • 9.7.5. gRNA Market - Mexico
      • 9.7.5.1. Mexico: gRNA Market, by Product & Services, 2019-2032 (USD Million)
      • 9.7.5.2. Mexico: gRNA Market, by End-Use, 2019-2032 (USD Million)
      • 9.7.5.3. Mexico: gRNA Market, by gRNA Type, 2019-2032 (USD Million)
      • 9.7.5.4. Mexico: gRNA Market, by Application, 2019-2032 (USD Million)
    • 9.7.6. gRNA Market - Brazil
      • 9.7.6.1. Brazil: gRNA Market, by Product & Services, 2019-2032 (USD Million)
      • 9.7.6.2. Brazil: gRNA Market, by End-Use, 2019-2032 (USD Million)
      • 9.7.6.3. Brazil: gRNA Market, by gRNA Type, 2019-2032 (USD Million)
      • 9.7.6.4. Brazil: gRNA Market, by Application, 2019-2032 (USD Million)
    • 9.7.7. gRNA Market - Argentina
      • 9.7.7.1. Argentina: gRNA Market, by Product & Services, 2019-2032 (USD Million)
      • 9.7.7.2. Argentina: gRNA Market, by End-Use, 2019-2032 (USD Million)
      • 9.7.7.3. Argentina: gRNA Market, by gRNA Type, 2019-2032 (USD Million)
      • 9.7.7.4. Argentina: gRNA Market, by Application, 2019-2032 (USD Million)

10. Competitive Landscape

  • 10.1. Expansion and Acquisition Analysis
    • 10.1.1. Expansion
    • 10.1.2. Acquisitions
  • 10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

  • 11.1. Agilent Technologies Inc.
    • 11.1.1. Company Overview
    • 11.1.2. Financial Performance
    • 11.1.3. Product Benchmarking
    • 11.1.4. Recent Development
  • 11.2. GENEWIZ (Azenta Life Sciences)
    • 11.2.1. Company Overview
    • 11.2.2. Financial Performance
    • 11.2.3. Product Benchmarking
    • 11.2.4. Recent Development
  • 11.3. Horizon Discovery Ltd.
    • 11.3.1. Company Overview
    • 11.3.2. Financial Performance
    • 11.3.3. Product Benchmarking
    • 11.3.4. Recent Development
  • 11.4. Jena Bioscience GmbH
    • 11.4.1. Company Overview
    • 11.4.2. Financial Performance
    • 11.4.3. Product Benchmarking
    • 11.4.4. Recent Development
  • 11.5. Merck KGaA
    • 11.5.1. Company Overview
    • 11.5.2. Financial Performance
    • 11.5.3. Product Benchmarking
    • 11.5.4. Recent Development
  • 11.6. Synbio Technologies
    • 11.6.1. Company Overview
    • 11.6.2. Financial Performance
    • 11.6.3. Product Benchmarking
    • 11.6.4. Recent Development
  • 11.7. Synthego
    • 11.7.1. Company Overview
    • 11.7.2. Financial Performance
    • 11.7.3. Product Benchmarking
    • 11.7.4. Recent Development
  • 11.8. System Biosciences, LLC.
    • 11.8.1. Company Overview
    • 11.8.2. Financial Performance
    • 11.8.3. Product Benchmarking
    • 11.8.4. Recent Development
  • 11.9. Takara Bio Inc.
    • 11.9.1. Company Overview
    • 11.9.2. Financial Performance
    • 11.9.3. Product Benchmarking
    • 11.9.4. Recent Development
  • 11.10. Thermo Fisher Scientific Inc
    • 11.10.1. Company Overview
    • 11.10.2. Financial Performance
    • 11.10.3. Product Benchmarking
    • 11.10.4. Recent Development